User contributions for Wilsonsa
From MicrobeWiki, the student-edited microbiology resource
9 December 2010
- 03:3503:35, 9 December 2010 diff hist +2 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Introduction
8 December 2010
- 05:0205:02, 8 December 2010 diff hist +60 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Telaprevir's mechanism of action: protease inhibition
- 05:0005:00, 8 December 2010 diff hist −5 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Telaprevir's mechanism of action: protease inhibition
- 04:5904:59, 8 December 2010 diff hist −14 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Target molecule: NS3-4A serine protease complex
- 04:4404:44, 8 December 2010 diff hist +5 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients No edit summary
- 04:3504:35, 8 December 2010 diff hist −1 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients No edit summary
- 04:3304:33, 8 December 2010 diff hist −273 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →References
- 04:3304:33, 8 December 2010 diff hist +1 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →References
- 04:3204:32, 8 December 2010 diff hist +1 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →References
- 04:3104:31, 8 December 2010 diff hist +291 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →References
- 04:3004:30, 8 December 2010 diff hist +25 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Telaprevir's mechanism of action: protease inhibition
- 04:3004:30, 8 December 2010 diff hist +158 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Telaprevir's mechanism of action: protease inhibition
- 04:2604:26, 8 December 2010 diff hist +40 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Telaprevir's mechanism of action: protease inhibition
- 04:2004:20, 8 December 2010 diff hist +2,554 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Telaprevir's mechanism of action: protease inhibition
- 03:2103:21, 8 December 2010 diff hist −3 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Target molecule: NS3-4A serine protease complex
- 03:2003:20, 8 December 2010 diff hist +11 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Alternate drugs
- 03:2003:20, 8 December 2010 diff hist −2 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Forestier et al.
- 03:1903:19, 8 December 2010 diff hist −2 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Forestier et al.
- 03:1903:19, 8 December 2010 diff hist −1 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Reesink et al.
- 03:1803:18, 8 December 2010 diff hist +2 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Projected pharmaceutical sales for 2011
- 03:1703:17, 8 December 2010 diff hist 0 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Alternate drugs
- 03:1703:17, 8 December 2010 diff hist 0 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Forestier et al.
- 03:1703:17, 8 December 2010 diff hist 0 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Reesink et al.
- 03:0403:04, 8 December 2010 diff hist +5 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Forestier et al.
- 03:0403:04, 8 December 2010 diff hist +105 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Reesink et al.
- 03:0003:00, 8 December 2010 diff hist +31 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Reesink et al.
- 02:5802:58, 8 December 2010 diff hist +234 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Reesink et al.
- 02:5202:52, 8 December 2010 diff hist −563 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Forestier et al.
- 02:4702:47, 8 December 2010 diff hist −2 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Alternate drugs
- 02:4602:46, 8 December 2010 diff hist +2 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Clinical study conclusions
- 02:4502:45, 8 December 2010 diff hist −3 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Introduction
- 02:4502:45, 8 December 2010 diff hist −7 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Introduction
- 02:4302:43, 8 December 2010 diff hist +25 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →HCV replication cyle
- 02:4202:42, 8 December 2010 diff hist −2 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →HCV replication cyle
- 02:4102:41, 8 December 2010 diff hist +4 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →HCV replication cyle
- 02:4002:40, 8 December 2010 diff hist +111 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →HCV replication cyle
- 02:3802:38, 8 December 2010 diff hist −4 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Telaprevir's mechanism of action: protease inhibition
- 02:3702:37, 8 December 2010 diff hist +129 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Telaprevir's mechanism of action: protease inhibition
- 02:3302:33, 8 December 2010 diff hist +10 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Target molecule: NS3-4A serine protease complex
- 02:3102:31, 8 December 2010 diff hist +63 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Telaprevir's mechanism of action: protease inhibition
- 02:2702:27, 8 December 2010 diff hist −1 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →References
- 02:2702:27, 8 December 2010 diff hist +248 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →References
- 02:1902:19, 8 December 2010 diff hist +294 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Telaprevir's mechanism of action: protease inhibition
- 01:5601:56, 8 December 2010 diff hist 0 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Telaprevir's mechanism of action: protease inhibition
- 01:5301:53, 8 December 2010 diff hist −10 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Telaprevir's mechanism of action: protease inhibition
- 01:5301:53, 8 December 2010 diff hist 0 N File:F3medium.gif No edit summary current
- 01:5001:50, 8 December 2010 diff hist 0 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Telaprevir's mechanism of action: protease inhibition
- 01:5001:50, 8 December 2010 diff hist +123 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Telaprevir's mechanism of action: protease inhibition
- 01:4901:49, 8 December 2010 diff hist 0 N File:Telaprevirprotease.jpg No edit summary current
- 01:4101:41, 8 December 2010 diff hist +4 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Target molecule: NS3-4A serine protease complex